Fruzaqla 1 mg/1
fruquintinib · CAPSULE · Takeda Pharmaceuticals America, Inc.
Fruzaqla (fruquintinib) is an oral capsule medication used to treat certain types of colorectal cancer. It works by blocking specific proteins that help cancer cells grow and spread.
Key Facts
- Brand Name
- Fruzaqla
- Generic Name
- fruquintinib
- NDC Code (Product)
63020-210- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Strength
- 1 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA217564
- Marketing Start
- 11/08/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Fruzaqla used for?
Fruzaqla (fruquintinib) is an oral capsule medication used to treat certain types of colorectal cancer. It works by blocking specific proteins that help cancer cells grow and spread.
Is Fruzaqla a controlled substance?
Fruzaqla is not classified as a controlled substance by the DEA.
What is the generic name for Fruzaqla?
The generic name for Fruzaqla is fruquintinib. There are no other listed brand versions of fruquintinib.
What is the NDC code for Fruzaqla 1 mg/1?
The NDC (National Drug Code) for Fruzaqla 1 mg/1 is 63020-210, listed by Takeda Pharmaceuticals America, Inc..
Other Fruzaqla Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)